Home > Insider Trading > Filing (0001424422-16-000036)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1504167	Biopharmx Corp	BPMX	Pharmaceutical Preparations (2834)	593843182

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1637670	Stephen Morlock	1098 Hamilton Court Menlo Park CA 94025		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-11-28	428,571	$0.35	543,956	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants to purchase common stock	Acquisiton	2016-11-28	321,428	$0.00	321,428	$0.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
321,428			No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	251,071	Indirect	By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03

Footnotes

Mr. Morlock is a co-trustee and co-beneficiary of the Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03
Securities are purchased as a unit, priced at $0.35 per unit, which consists of one share of common stock and one warrant to purchase 0.75 of a share of common stock.
Warrants become exercisable upon the later of the one year anniversary from issuance and receiving stockholder approval to increase the number of authorized shares of common stock.
Warrants expire 7 years from the exercisability date.